Filtered By:
Cancer: Cancer
Management: Partnerships

This page shows you your search results in order of date.

Order by Relevance | Date

Total 122 results found since Jan 2013.

‘This will happen before 2030’: how the science behind Covid vaccines might help to fight cancer
The success of mRNA-based drugs in combating coronavirus is inspiring scientists to create similar vaccines for melanoma and other tumoursIn December 2022, the US biotech firm Moderna, a company that emerged from relative obscurity to become a household name during the pandemic, published theresults of a clinical trialthat sent ripples through the world of cancer research.Conducted in partnership with the pharma company MSD, it demonstrated that a messenger RNA (mRNA) cancer vaccine, used in combination with immunotherapy, could offer significant benefit to patients with advanced melanoma who had received surgery to remove...
Source: Guardian Unlimited Science - January 22, 2023 Category: Science Authors: David Cox Tags: Cancer research Medical research Coronavirus Infectious diseases Science Source Type: news

New | 134 studies released in batch on 2022-12-02
phs002520.v1.p1 | Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): Community Based COVID-19 Testing Evaluation (study page |release notes )phs002521.v1.p1 | Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): Creating a Sustainable Infrastructure for SARS-CoV-2 Testing at Syringe Exchange Programs (study page |release notes )phs002522.v1.p1 | Rapid Acceleration of Diagnostics - Radical (RADx-rad): MOF-SCENT: Metal-Organic Frameworks for Screening COVID-19 by Electronic-Nose Technology to Improve Selectivity and Time Response (study page |release notes )phs002523.v1.p...
Source: dbGaP, the database of Genotypes and Phenotypes - December 2, 2022 Category: Genetics & Stem Cells Tags: BatchStudyRelease Source Type: research

Popular Dry Shampoos Found to Have Cancer-Causing Chemical
Top-selling dry shampoos including Not Your Mother’s and Church & Dwight Co.’s Batiste contain high levels of benzene, the cancer-causing chemical that led Unilever to yank its product from shelves in October, according to a new independent study. Valisure, a New Haven, Connecticut-based analytical laboratory, tested 148 batches from 34 brands of spray-on dry shampoo and found that 70% contained benzene. The chemical can cause certain blood cancers, such as leukemia. The company filed a petition Monday with the U.S. Food and Drug Administration seeking to have the products that contain the substance recalle...
Source: TIME: Health - November 2, 2022 Category: Consumer Health News Authors: Anna Edney/Bloomberg Tags: Uncategorized healthscienceclimate Public Health wire Source Type: news

This COVID-19 sleuth is making friends and foes advocating for African science
.news-article__hero--featured .parallax__element{ object-position: 60% 20%; -o-object-position: 60% 20%; } This story was supported by the Pulitzer Center. As Americans began to stir in the early morning hours of Thanksgiving Day 2021, a rapt international press corps was listening as a pony-tailed scientist in South Africa announced the identification of a worrisome new SARS-CoV-2 variant. Tulio de Oliveira, a Brazilian-born bioinformatician, explained that many of the variant’s dozens of mutations might make it more immune evasive and contagious—and that it was spreading “very fast” in South Africa. ...
Source: Science of Aging Knowledge Environment - October 6, 2022 Category: Geriatrics Source Type: research

Weekly Overseas Health IT Links –1st October, 2022.
This article details information required for integration into EHRs to build personalized treatment plans and develop successful SDOH programs that provide resources and support for patients in need. In addition, successful SDOH programs implemented by Kaiser Permanente and Boston Medical Center showcase how supporting clinicians with real-time SDOH data can lead to patient-centric care. Create a 360-Degree Patient View Through TechnologyThe Office of the National Coordinator for Health Information Technology (ONC)indicatesthat the “collection, documentation, reporting, access, and use of SDOH data … can be used t...
Source: Australian Health Information Technology - October 1, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

Weekly Overseas Health IT Links –10th September, 2022.
This article is adapted fromVoices in the Code: A Story About People, Their Values, and the Algorithm They Made,out Sept. 8 from Russell Sage Foundation Press.In May 2021, I got a call I never expected. I was working on abook about A.I. ethics, focused on the algorithm that gives out kidneys to transplant patients in the United States. Darren Stewart —a data scientist from UNOS, the nonprofit that runs the kidney allocation process—was calling to get my take: How many decimal places should they include when calculating each patient’s allocation score? The score is an incredibly important number, given it determines w...
Source: Australian Health Information Technology - September 10, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

FREE CONTACT HOUR: JHSON Virtual Nursing Grand Rounds
p{ margin:10px 0; padding:0; } table{ border-collapse:collapse; } h1,h2,h3,h4,h5,h6{ display:block; margin:0; padding:0; } img,a img{ border:0; height:auto; outline:none; text-decoration:none; } body,#bodyTable,#bodyCell{ height:100%; margin:0; padding:0; width:100%; } .mcnPreviewText{ display:none !important; } #outlook a{ padding:0; } img{ -ms-interpolation-mode:bicubic; } table{ mso-table-lspace:0pt; mso-table-rspace:0pt; } .ReadMsgBody{ width:100%; } .ExternalClass{ width:100%; } p,a,li,td,blockquote{ m...
Source: Johns Hopkins University and Health Systems Archive - August 10, 2022 Category: Nursing Source Type: news

Weekly Overseas Health IT Links – 26th March, 2022.
Here are a few I came across last week.Note: Each link is followed by a title and few paragraphs. For the full article click on the link above title of the article. Note also that full access to some links may require site registration or subscription payment.-----https://mhealthintelligence.com/news/55-of-telehealth-providers-frustrated-with-overblown-patient-expectations55% of Telehealth Providers Frustrated With Overblown Patient ExpectationsProviders also cited their ability to provide quality care and technical difficulties as among their top frustrations with telehealth, a new survey shows.ByAnuja VaidyaMarch 18, 202...
Source: Australian Health Information Technology - March 26, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine
Cancer J. 2022 Mar-Apr 01;28(2):146-150. doi: 10.1097/PPO.0000000000000587.ABSTRACTThe sudden emergence of the coronavirus disease 2019 (COVID-19) pandemic in early 2020 stimulated unprecedented scientific initiatives to rapidly develop effective treatments and vaccines. One example was the development of vaccines based on messenger RNA platforms, which received emergency use authorization in the United States less than 1 year after the primary sequence of the severe acute respiratory syndrome coronavirus 2 virus was published. Novel practices arose from the collaborative efforts and inclusive clinical studies that facilit...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Randall N Hyer Source Type: research

Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and Care
Cancer J. 2022 Mar-Apr 01;28(2):118-120. doi: 10.1097/PPO.0000000000000584.ABSTRACTThe COVID-19 (coronavirus disease 2019) pandemic has worldwide implications on health care, especially in our most vulnerable population: cancer patients. Flexibility and adaptation are needed to continue clinical research and for clinical trial development. At the Intramural Research Program, National Cancer Institute, swift changes have been implemented to protect our patients while maintaining the scientific integrity of our cancer clinical trials. Many lessons have been learned including incorporation of telehealth into clinical trials, ...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Fatima Karzai William L Dahut Source Type: research

Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine
Cancer J. 2022 Mar-Apr 01;28(2):146-150. doi: 10.1097/PPO.0000000000000587.ABSTRACTThe sudden emergence of the coronavirus disease 2019 (COVID-19) pandemic in early 2020 stimulated unprecedented scientific initiatives to rapidly develop effective treatments and vaccines. One example was the development of vaccines based on messenger RNA platforms, which received emergency use authorization in the United States less than 1 year after the primary sequence of the severe acute respiratory syndrome coronavirus 2 virus was published. Novel practices arose from the collaborative efforts and inclusive clinical studies that facilit...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Randall N Hyer Source Type: research

Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and Care
Cancer J. 2022 Mar-Apr 01;28(2):118-120. doi: 10.1097/PPO.0000000000000584.ABSTRACTThe COVID-19 (coronavirus disease 2019) pandemic has worldwide implications on health care, especially in our most vulnerable population: cancer patients. Flexibility and adaptation are needed to continue clinical research and for clinical trial development. At the Intramural Research Program, National Cancer Institute, swift changes have been implemented to protect our patients while maintaining the scientific integrity of our cancer clinical trials. Many lessons have been learned including incorporation of telehealth into clinical trials, ...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Fatima Karzai William L Dahut Source Type: research

Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine
Cancer J. 2022 Mar-Apr 01;28(2):146-150. doi: 10.1097/PPO.0000000000000587.ABSTRACTThe sudden emergence of the coronavirus disease 2019 (COVID-19) pandemic in early 2020 stimulated unprecedented scientific initiatives to rapidly develop effective treatments and vaccines. One example was the development of vaccines based on messenger RNA platforms, which received emergency use authorization in the United States less than 1 year after the primary sequence of the severe acute respiratory syndrome coronavirus 2 virus was published. Novel practices arose from the collaborative efforts and inclusive clinical studies that facilit...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Randall N Hyer Source Type: research

Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and Care
Cancer J. 2022 Mar-Apr 01;28(2):118-120. doi: 10.1097/PPO.0000000000000584.ABSTRACTThe COVID-19 (coronavirus disease 2019) pandemic has worldwide implications on health care, especially in our most vulnerable population: cancer patients. Flexibility and adaptation are needed to continue clinical research and for clinical trial development. At the Intramural Research Program, National Cancer Institute, swift changes have been implemented to protect our patients while maintaining the scientific integrity of our cancer clinical trials. Many lessons have been learned including incorporation of telehealth into clinical trials, ...
Source: Cancer Journal - March 25, 2022 Category: Cancer & Oncology Authors: Fatima Karzai William L Dahut Source Type: research